Quest Diagnostics Incorporated · NYSE:DGX

T. Rowe Price Associates Inc reported a 6.50% stake in Quest Diagnostics Incorporated (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

T. Rowe Price Associates Inc reported a 6.50% stake in Quest Diagnostics Incorporated, 7,209,622 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
6.50%
Shares
7,209,622
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.6.50%7,209,622

Source

View original at SEC

Related